Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification

17 Sept 2009

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to HER2/EGFR in Cancer Research
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19760503
DOI: 10.1007/s10549-009-0539-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplificationPMID 19760503Read ↗

Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare eventSemantic proximity Read ↗

Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinomaSemantic proximity Read ↗

HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity.Semantic proximity Read ↗

Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17.Semantic proximity Read ↗

The Influence of Polysomy 17 on HER2 Gene and Protein Expression in Adenocarcinoma of the BreastSemantic proximity Read ↗

Impact of an alternative chromosome 17 probe and the 2013 American Society of Clinical Oncology and College of American Pathologists guidelines on fluorescence in situ hybridization for the determination of HER2 gene amplification in breast cancerSemantic proximity Read ↗

Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situhybridization and immunohistochemistrySemantic proximity Read ↗

Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.Semantic proximity Read ↗

Therapeutic strategies in male breast cancer: clinical implications of chromosome 17 gene alterations and molecular subtypes.Semantic proximity Read ↗

Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.Semantic proximity Read ↗

Prognostic significance of centromere 17 copy number gain in breast cancer depends on breast cancer subtype.Semantic proximity Read ↗

Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 TestingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.